• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Mil­li­pore­Sig­ma in­vests €70M to triple ADC man­u­fac­tur­ing at US site 

7 months ago
Manufacturing

PacBio bets on 'in­flec­tion point' with $500 long-read genome

7 months ago
R&D
Diagnostics

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

7 months ago
Deals
Pharma

In bid to low­er ARIA-E, Eli Lil­ly tries a dif­fer­ent dos­ing reg­i­men for its Alzheimer's drug

7 months ago
R&D
Pharma

Ve­ra’s $300M of­fer­ing; Abeona re­sub­mits treat­ment for rare skin dis­ease

7 months ago
News Briefing

Two type 1 di­a­betes pa­tients are in­sulin-free af­ter Ele­don's im­muno­sup­pres­sant and an islet trans­plant

7 months ago
R&D

GSK buys au­toim­mune T cell en­gager for $300M up­front from Chim­a­gen

7 months ago
Deals

Eye­point sells $100M in shares af­ter un­veil­ing eye dis­ease da­ta for drug-de­vice as­set

7 months ago
R&D

#HLTH24: GLP-1 com­pound­ing phar­ma­cies took cen­ter stage at dig­i­tal health’s biggest con­fer­ence

7 months ago
Pharma
FDA+

Pathos AI nabs $62M Se­ries C as it hunts for more Phase 1 drugs with AI

7 months ago
Financing
AI

Paragon launch­es an­oth­er com­pa­ny in hot PD-1xVEGF space that goes straight to re­verse merg­er

7 months ago
Deals

Up­dat­ed: Pfiz­er’s Covid pill pow­ers guid­ance raise, but short­fall else­where rais­es ques­tions

7 months ago
Pharma

Cor­rect­ed: Gen­mab lines up T cell en­gager pact with Re­vi­tope

7 months ago
Startups
Deals

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

7 months ago
Deals
R&D

Iambic at­tempts to ‘break the wall’ be­tween the lab and clin­ic with new AI mod­el

7 months ago
AI

#HLTH24: How Nvidia plans to pro­vide the build­ing blocks of AI in health tech

7 months ago
AI
Health Tech

WuXi AppTec is still sign­ing on new clients de­spite Biose­cure threat

7 months ago
China
Manufacturing

Pfiz­er’s make-or-break quar­ter

7 months ago
Editor's note
Pharma

Bi­par­ti­san let­ter ques­tions FDA's 'nar­row' in­ter­pre­ta­tion for pri­or­i­ty re­view vouch­ers

7 months ago
Pharma
FDA+

Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

7 months ago
R&D
Pharma

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

7 months ago
China
Pharma

Bio­gen's full Ph2 da­ta for IgA nephropa­thy drug; Sanofi in­vests in obe­si­ty biotech

7 months ago
News Briefing

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

7 months ago
Startups
Deals

HOPO Ther­a­peu­tics wins up to $226M BAR­DA con­tract for heavy met­al poi­son­ing re­search

7 months ago
R&D
First page Previous page 84858687888990 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times